Acrobiosystems Co.Ltd.

Baipusaisi disclosed its 2026 semi-annual report on August 29. In the first half of the year, total operating revenue reached 500 million yuan, up 28.97% year-on-year; net profit attributable to the parent company was 98.3562 million yuan, up 17.36% year-on-year; non-GAAP net profit was 89.8339 million yuan, up 6.78% year-on-year. Net cash flow from operating activities was 96.3915 million yuan, up 25.71% year-on-year. Basic earnings per share were 0.5883 yuan, and the weighted average return on equity was 3.63%, up 0.43 percentage points year-on-year. As of the end of the first half, the company's inventory book value was 277 million yuan, accounting for 10.43% of net assets, with an inventory write-down provision ratio of 33.96%.

ACROBiosystems announced plans to repurchase shares totaling no less than 25 million yuan and no more than 50 million yuan, with a maximum repurchase price of 60 yuan per share. The estimated number of shares to be repurchased is approximately 420,000 to 830,000 shares, representing 0.25% to 0.50% of total share capital. In the first quarter of 2026, the company achieved revenue of 236 million yuan and net profit attributable to the parent of 46.26 million yuan.